Ligament Rupture
Conditions
Brief summary
This study evaluates the effectiveness of a pre-habilitation stay via digital monitoring on patients' short-term post-operative anxiety, compared with conventional management.
Detailed description
This is a prospective, comparative, randomized (2-arm), controlled, single-center study of two management modalities. Recruitment will focus on adult patients with anterior cruciate ligament rupture and scheduled anterior cruciate ligament surgical reconstruction. Patients will be randomized into 2 arms, an experimental arm A (pre-habilitation management) and a control arm B (conventional management).
Interventions
surgical reconstruction after rupture of the anterior cruciate ligament is widely proposed as first-line treatment, with the aim of restoring knee joint stability and facilitating functional recovery
Sponsors
Study design
Eligibility
Inclusion criteria
* Age\>18; * Partial or complete tear of the anterior cruciate ligament; * Scheduled anterior cruciate ligament reconstructive surgery; * Patient with a tablet, computer or smartphone with an internet connection; * Patient able to understand and read French; * Willingness to complete questionnaires at regular intervals; * Membership of a social security scheme; * Signed informed consent.
Exclusion criteria
* History of anterior cruciate ligament surgery within the past 5 years; * Stage III collateral ligament injury; * Osteotomy; * Neurological (motor and/or sensory), vestibular or rheumatic pathology; * Pregnant or breast-feeding woman; * Protected adult patient (under guardianship, curatorship or deprivation of liberty).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| State-Trait Anxiety Inventory questionnaire | 7 days | The main evaluation criterion is the total "state-anxiety" score of the State-Trait Anxiety Inventory questionnaire on 7 days compared to the score measured at least 25 days (i.e. baseline value: before the surgical intervention and before the pre-habilitation stay taking place for patients in the experimental group) |
Countries
France